The multidistrict litigation recently established for Stryker hip lawsuits involving recalled LFIT V40 Femoral Heads is about to get underway. According to an Order issued in the U.S. District Court, District of Massachusetts, on April 21st, the proceeding’s Initial Status … Continue reading
Johnson & Johnson continues to face challenges over Invokana. In addition to slowing U.S. sales, the Type 2 diabetes drug continues to be the subject of a growing product liability litigation involving diabetic ketoacidosis and other side effects allegedly associated … Continue reading
Plaintiffs pursuing Zofran birth defects lawsuits recorded a win yesterday after a federal judge in Massachusetts found that fraud-based allegations involving the drug’s labeling were adequately pled. However, U.S. District Judge F. Dennis Saylor IV did dismiss some fraud-based claims … Continue reading
Sales of the Zecuity Migraine Patch were suspended last year after numerous patients reportedly experienced burns and scarring at the application site. Unfortunately, a review of Zecuity’s troubled approval history indicates that these safety issues were actually a long-standing problem. … Continue reading
Ethicon, Inc. has indicated its opposition to a proposal that would centralize all federally-filed hernia mesh lawsuits involving its Physiomesh Flexible Composite Mesh product in a single jurisdiction. In a response filed last week with the U.S. Judicial Panel on … Continue reading
The federal litigation involving Taxotere and permanent hair loss continued to grow at a significant pace over the past month. A recent update from the U.S. Judicial Panel on Multidistrict Litigation (JPML) indicates that 949 cases were pending in the … Continue reading
The North American market for elbow replacement is expected to grow by at least 3.6% annually, according to the research and consulting firm GlobalData. Most of the growth is expected to come from the U.S., where, ironically, federal regulators only … Continue reading
St. Jude Medical continues to endure fallout from safety controversies that recently ensnared some of its implantable cardiac defibrillators. Just yesterday, the U.S. Food & Drug Administration (FDA) took the company to task for the way it handled those problems. … Continue reading
Opening arguments in Missouri’s fifth trial involving the alleged link between Johnson & Johnson talcum powders and ovarian cancer began Tuesday, with a Plaintiff’s attorneys telling jurors that the healthcare products giant placed its desire to protect profits over the … Continue reading
The Philadelphia Court of Common Pleas is now home to more than 5,500 Risperdal lawsuits, thanks to a spike in filings during the first three months of the year. Much of the increase may be due to Johnson & Johnson’s … Continue reading